Trending NewsTrending NewsNYSE:DGX Quest Diagnostics (DGX) Stock Price, News & Analysis $241.48 -1.80 (-0.74%) Closing price 10/23/2026 03:59 PM EasternExtended Trading$240.50 -0.99 (-0.41%) As of 10/23/2026 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Quest Diagnostics Stock (NYSE:DGX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Quest Diagnostics alerts:Sign Up Key Stats Today's Range$239.63▼$244.3350-Day Range$226.94▼$247.4952-Week Range$171.18▼$248.84Volume933,379 shsAverage Volume1.08 million shsMarket Capitalization$26.65 billionP/E Ratio24.05Dividend Yield1.42%Price Target$244.27Consensus RatingModerate Buy Company Overview Quest Diagnostics Incorporated (NYSE: DGX) is a provider of diagnostic information services. The company performs laboratory testing that helps physicians, hospitals and other healthcare providers diagnose, treat and monitor diseases and health conditions. Its services include routine blood and other specimen testing, pathology, molecular and genetic testing, and specialized diagnostic services. Quest Diagnostics serves a broad range of customers, including hospitals, physician practices, health plans, employers, government agencies and individual consumers. Through its laboratory network, patient service centers and digital tools, the company supports clinical decision-making, preventive care, wellness programs and occupational health services. It also provides drug testing and other workforce-related testing programs. The company traces its origins to the clinical laboratory operations of Corning Incorporated and became an independent public company in 1996 before adopting the Quest Diagnostics name. Its operations are primarily based in the United States, with services delivered through facilities and collection locations across the country. Quest Diagnostics is led by Chief Executive Officer Jim Davis.AI Generated. May Contain Errors. Read More Quest Diagnostics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks85th Percentile Overall ScoreDGX MarketRank™: 4.24671317413 of 5 starsQuest Diagnostics scored higher than 85% of companies evaluated by MarketBeat, and ranked 69th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingModerate Buy Consensus RatingQuest Diagnostics has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 3 buy ratings, 6 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for Quest Diagnostics is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageQuest Diagnostics has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Quest Diagnostics' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth6.03% Earnings GrowthEarnings for Quest Diagnostics are expected to grow by 6.03% in the coming year, from $11.27 to $11.95 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Quest Diagnostics is 24.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.39.Price to Earnings Ratio vs. SectorThe P/E ratio of Quest Diagnostics is 24.05, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.33.Price to Earnings Growth RatioQuest Diagnostics has a PEG Ratio of 2.17. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioQuest Diagnostics has a P/B Ratio of 3.35. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.12% of the float of Quest Diagnostics has been sold short.Short Interest Ratio / Days to CoverQuest Diagnostics has a short interest ratio ("days to cover") of 2.69, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Quest Diagnostics has recently decreased by 5.08%, indicating that investor sentiment is improving significantly. Dividend4.2 / 5Dividend StrengthStrong Dividend YieldQuest Diagnostics pays a meaningful dividend of 1.42%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthQuest Diagnostics has been increasing its dividend for 14 years.Dividend CoverageThe dividend payout ratio of Quest Diagnostics is 34.26%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Quest Diagnostics will have a dividend payout ratio of 28.79% next year. This indicates that Quest Diagnostics will be able to sustain or increase its dividend.Read more about Quest Diagnostics' dividend. News and Social Media2.8 / 5News Sentiment0.47 News SentimentQuest Diagnostics has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 38 news articles for Quest Diagnostics this week, compared to 6 articles on an average week.Search InterestOnly 7 people have searched for DGX on MarketBeat in the last 30 days. This is a decrease of -30% compared to the previous 30 days.MarketBeat Follows3 people have added Quest Diagnostics to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Quest Diagnostics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,316,493.00 in company stock.Percentage Held by Insiders0.88% of the stock of Quest Diagnostics is held by insiders.Percentage Held by Institutions88.06% of the stock of Quest Diagnostics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Quest Diagnostics' insider trading history. Receive DGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quest Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DGX Stock News HeadlinesAnalysts Have Conflicting Sentiments on These Healthcare Companies: Molina Healthcare (MOH), Quest Diagnostics (DGX) and Argenx Se (ARGX)October 24 at 12:05 AM | theglobeandmail.comQuest Diagnostics (DGX) Stock Price Stalls After Strong Q3 EarningsOctober 24 at 3:46 AM | finance.yahoo.comHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading Apple, Tesla, or Bitcoin. He targets overlooked small-cap stocks that can move fast: $1.50 to $98.40 in a week, $6 to $34 in hours, or 49 cents to $10 in days. Now he is sharing the exact setup he watches for before these moves happen.October 25 at 1:00 AM | Tim Sykes (Ad)Quest Diagnostics (DGX) Backs At Home Cervical Cancer ScreeningOctober 23 at 10:34 PM | finance.yahoo.comQuest Diagnostics Earnings Call Signals Confident GrowthOctober 23 at 8:31 PM | tipranks.comQuest Diagnostics (DGX) Stock Could Be Undervalued Despite Raised Full Year GuidanceOctober 23 at 5:33 PM | finance.yahoo.comPRIVACY ALERT: AWKO Law LLP Investigates Quest Diagnostics for Data Breach of Patient RecordsOctober 23 at 4:33 PM | businesswire.comDeutsche Bank Adjusts Quest Diagnostics PT to $245 From $232, Maintains Hold RatingOctober 23 at 12:30 PM | marketscreener.comMSee More Headlines DGX Stock Analysis - Frequently Asked Questions How have DGX shares performed this year? Quest Diagnostics' stock was trading at $173.47 at the start of the year. Since then, DGX shares have increased by 39.2% and is now trading at $241.4850. How were Quest Diagnostics' earnings last quarter? Quest Diagnostics Incorporated (NYSE:DGX) issued its quarterly earnings results on Thursday, October, 22nd. The medical research company reported $3.00 earnings per share for the quarter, topping analysts' consensus estimates of $2.87 by $0.13. The business's revenue was up 10.0% on a year-over-year basis. Read the conference call transcript. How will Quest Diagnostics' stock buyback program work? Quest Diagnostics' Board of Directors initiated a share repurchase plan on Tuesday, February 10th 2026, which allows the company to repurchase $1,000,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 4.7% of its shares through open market purchases. Shares buyback plans are typically an indication that the company's board believes its shares are undervalued. Does Quest Diagnostics have any subsidiaries? Quest Diagnostics subsidiaries include these companies: MACL, Blueprint Genetics, PhenoPath Laboratories, ReproSource, California Laboratory Associates, Cleveland HeartLab, Cape Cod Healthcare - Business, and more. When did Quest Diagnostics IPO? Quest Diagnostics (DGX) raised $12 million in an initial public offering (IPO) on Tuesday, January 7th 2025. The company issued 2,300,000 shares at a price of $4.00-$6.00 per share. Dominari Securities and Revere Securities served as the underwriters for the IPO. Who are Quest Diagnostics' major shareholders? Top institutional investors of Quest Diagnostics include Eastern Bank (0.19%), Robeco Institutional Asset Management B.V. (0.11%), Willis Investment Counsel (0.11%) and Simplicity Wealth LLC (0.02%). Insiders that own company stock include J E Davis, Catherine T Doherty, Michael E Prevoznik, Michael J Deppe, Gary M Pfeiffer, Vicky B Gregg, Patrick Plewman, Karthik Kuppusamy and Mark E Delaney. View institutional ownership trends. How do I buy shares of Quest Diagnostics? Shares of DGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Quest Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Quest Diagnostics investors own include Pfizer (PFE), NVIDIA (NVDA), Qualcomm (QCOM), AbbVie (ABBV), Johnson & Johnson (JNJ), JPMorgan Chase & Co. (JPM) and Cisco Systems (CSCO). Company Calendar Record date for 10/21 Dividend10/06/2026Ex-Dividend for 10/21 Dividend10/06/2026Dividend Payable10/21/2026Last Earnings10/22/2026Today10/25/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 DGX's financial health is in the Green zone, according to TradeSmith. DGX has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSE:DGX CIK1022079 Webwww.questdiagnostics.com Phone(973) 520-2700Fax201-462-4169Employees57,000Year Founded1967Price Target and Rating Average Price Target for Quest Diagnostics$244.27 High Price Target$262.00 Low Price Target$200.00 Potential Upside/Downside+1.2%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)$10.04 Trailing P/E Ratio24.05 Forward P/E Ratio21.43 P/E Growth2.17Net Income$992 million Net Margins9.53% Pretax Margin12.60% Return on Equity16.21% Return on Assets7.41% Debt Debt-to-Equity Ratio0.70 Current Ratio1.70 Quick Ratio1.46 Sales & Book Value Annual Sales$11.04 billion Price / Sales2.42 Cash Flow$15.15 per share Price / Cash Flow15.94 Book Value$72.03 per share Price / Book3.35Miscellaneous Outstanding Shares110,370,000Free Float109,402,000Market Cap$26.65 billion OptionableOptionable Beta0.54 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSE:DGX) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our Partners$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | SponsoredWhy tech stocks are deadAI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the b...Porter & Company | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredCigar Lake Flooded Again Uranium Supply Shock RepeatsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...Digest Publishing | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredAsk a 20 Year Trading Pro Your Stock Questions Live for 5Ross Givens, a market analyst with over 20 years on Wall Street, goes live every Monday at 9 AM ET to break do...Traders Agency | SponsoredThe data center backlash is creating a rare investing opportunityA new Gallup poll shows 70% of Americans want AI data centers kept out of their communities - and futurist Geo...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest Diagnostics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest Diagnostics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.